Analysts: Sagent Pharmaceuticals Inc (SGNT.OQ)
SGNT.OQ on NASDAQ Stock Exchange Global Market
21.26USD
1:02pm EDT
21.26USD
1:02pm EDT
Price Change (% chg)
$-0.42 (-1.94%)
$-0.42 (-1.94%)
Prev Close
$21.68
$21.68
Open
$21.74
$21.74
Day's High
$21.74
$21.74
Day's Low
$20.88
$20.88
Volume
7,412
7,412
Avg. Vol
37,501
37,501
52-wk High
$23.25
$23.25
52-wk Low
$12.66
$12.66
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Outperform | 0.00 | December | 2 Aug 2013 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 1 | 1 | 1 | 1 |
| (2) OUTPERFORM | 2 | 2 | 2 | 2 |
| (3) HOLD | 5 | 5 | 5 | 5 |
| (4) UNDERPERFORM | 0 | 0 | 0 | 0 |
| (5) SELL | 0 | 0 | 0 | 0 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 2.50 | 2.50 | 2.50 | 2.50 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 7 | 61.40 | 65.20 | 58.00 | -- |
| Quarter Ending Dec-13 | 7 | 64.89 | 69.30 | 59.70 | -- |
| Year Ending Dec-13 | 8 | 245.97 | 258.40 | 237.40 | 320.42 |
| Year Ending Dec-14 | 8 | 291.96 | 310.30 | 274.10 | 410.50 |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | 8 | 0.00 | 0.07 | -0.08 | 0.15 |
| Quarter Ending Dec-13 | 8 | 0.02 | 0.09 | -0.08 | 0.15 |
| Year Ending Dec-13 | 7 | 0.36 | 0.51 | 0.16 | 0.91 |
| Year Ending Dec-14 | 8 | 0.52 | 0.91 | -0.03 | 1.61 |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Mar-13 | 55.31 | 60.21 | 4.90 | 8.85 |
| Quarter Ending Dec-12 | 52.07 | 53.23 | 1.16 | 2.23 |
| Quarter Ending Sep-12 | 48.60 | 49.43 | 0.83 | 1.71 |
| Quarter Ending Jun-12 | 39.69 | 42.68 | 2.99 | 7.55 |
| Quarter Ending Mar-12 | 42.31 | 38.28 | 4.03 | 9.53 |
| Earnings (per share) | ||||
| Quarter Ending Mar-13 | -0.03 | 0.17 | 0.20 | -780.00 |
| Quarter Ending Dec-12 | -0.20 | 0.00 | 0.20 | -100.00 |
| Quarter Ending Sep-12 | -0.20 | -0.13 | 0.07 | -35.71 |
| Quarter Ending Jun-12 | -0.26 | -0.17 | 0.09 | -34.94 |
| Quarter Ending Mar-12 | -0.28 | -0.30 | 0.02 | -8.85 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 61.40 | 63.08 | 61.64 | 61.64 | -- |
| Quarter Ending Dec-13 | 64.89 | 66.18 | 64.95 | 64.95 | -- |
| Year Ending Dec-13 | 245.97 | 249.69 | 245.33 | 245.33 | 320.42 |
| Year Ending Dec-14 | 291.96 | 295.38 | 294.60 | 294.60 | 410.50 |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | 0.00 | 0.01 | 0.00 | 0.00 | 0.15 |
| Quarter Ending Dec-13 | 0.02 | 0.02 | 0.02 | 0.02 | 0.15 |
| Quarter Ending Dec-13 | 0.36 | 0.36 | 0.33 | 0.33 | 0.91 |
| Quarter Ending Dec-14 | 0.52 | 0.55 | 0.54 | 0.54 | 1.61 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Sep-13 | 0 | 1 | 1 | 1 |
| Quarter Ending Dec-13 | 0 | 1 | 0 | 1 |
| Year Ending Dec-13 | 0 | 1 | 1 | 1 |
| Year Ending Dec-14 | 0 | 1 | 1 | 1 |
| Earnings | ||||
| Quarter Ending Sep-13 | 0 | 1 | 1 | 1 |
| Quarter Ending Dec-13 | 0 | 1 | 0 | 1 |
| Year Ending Dec-13 | 0 | 1 | 2 | 0 |
| Year Ending Dec-14 | 0 | 1 | 1 | 1 |
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Jefferson Research
|
$20.00
|
|
Provider: TheStreet.com Ratings
|
$10.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Earnings vs.
Estimates